Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
申请公布号
WO2012178015(A2)
申请公布日期
2012.12.27
申请号
WO2012US43757
申请日期
2012.06.22
申请人
ZENOBIA THERAPEUTICS, INC.;BOUNAUD, PIERRE-YVES;NIENABER, VICKI;STEENSMA, RUO, W.;LOWE, JOHN, A., III
发明人
BOUNAUD, PIERRE-YVES;NIENABER, VICKI;STEENSMA, RUO, W.;LOWE, JOHN, A., III
